• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有疗效的订书钉状、长效胰高血糖素样肽 2 类似物在葡聚糖硫酸钠诱导的小鼠结肠炎模型中的应用。

Stapled, Long-Acting Glucagon-like Peptide 2 Analog with Efficacy in Dextran Sodium Sulfate Induced Mouse Colitis Models.

机构信息

California Institute for Biomedical Research , La Jolla , California 92037 , United States.

Department of Chemistry, The Skaggs Institute for Chemical Biology , The Scripps Research Institute , La Jolla , California 92037 , United States.

出版信息

J Med Chem. 2018 Apr 12;61(7):3218-3223. doi: 10.1021/acs.jmedchem.7b00768. Epub 2018 Mar 23.

DOI:10.1021/acs.jmedchem.7b00768
PMID:29528634
Abstract

Glucagon-like peptide 2 (GLP-2) is a hormone that has been shown to stimulate intestinal growth and attenuate intestinal inflammation. Despite being efficacious in a variety of animal models of disease, its therapeutic potential is hampered by the short half-life in vivo. We now describe a highly potent, stapled long-acting GLP-2 analog, peptide 10, that has a more than 10-fold longer half-life than teduglutide and improved intestinotrophic and anti-inflammatory effects in mouse models of DSS-induced colitis.

摘要

胰高血糖素样肽 2(GLP-2)是一种激素,已被证明可刺激肠道生长并减轻肠道炎症。尽管在多种疾病的动物模型中均有效,但由于其体内半衰期短,其治疗潜力受到限制。我们现在描述了一种高效、订书钉式长效 GLP-2 类似物,即肽 10,其半衰期比 teduglutide 长 10 多倍,并且在 DSS 诱导的结肠炎小鼠模型中具有更好的肠营养和抗炎作用。

相似文献

1
Stapled, Long-Acting Glucagon-like Peptide 2 Analog with Efficacy in Dextran Sodium Sulfate Induced Mouse Colitis Models.具有疗效的订书钉状、长效胰高血糖素样肽 2 类似物在葡聚糖硫酸钠诱导的小鼠结肠炎模型中的应用。
J Med Chem. 2018 Apr 12;61(7):3218-3223. doi: 10.1021/acs.jmedchem.7b00768. Epub 2018 Mar 23.
2
Glugacon-like peptide-2: broad receptor expression, limited therapeutic effect on intestinal inflammation and novel role in liver regeneration.胰高血糖素样肽-2:广泛的受体表达,对肠道炎症的治疗效果有限,以及在肝脏再生中的新作用。
Am J Physiol Gastrointest Liver Physiol. 2014 Aug 1;307(3):G274-85. doi: 10.1152/ajpgi.00389.2012. Epub 2014 May 29.
3
Novel GLP-1/GLP-2 co-agonists display marked effects on gut volume and improves glycemic control in mice.新型胰高血糖素样肽-1/胰高血糖素样肽-2共激动剂对小鼠肠道容积有显著影响,并改善血糖控制。
Physiol Behav. 2018 Aug 1;192:72-81. doi: 10.1016/j.physbeh.2018.03.004. Epub 2018 Mar 11.
4
Purified PEGylated porcine glucagon-like peptide-2 reduces the severity of colonic injury in a murine model of experimental colitis.纯化的聚乙二醇化猪胰高血糖素样肽-2可减轻实验性结肠炎小鼠模型的结肠损伤严重程度。
Peptides. 2014 Feb;52:11-8. doi: 10.1016/j.peptides.2013.11.012. Epub 2013 Nov 23.
5
The effects of a TGR5 agonist and a dipeptidyl peptidase IV inhibitor on dextran sulfate sodium-induced colitis in mice.TGR5激动剂和二肽基肽酶IV抑制剂对葡聚糖硫酸钠诱导的小鼠结肠炎的影响。
J Gastroenterol Hepatol. 2015 Mar;30 Suppl 1(Suppl 1):60-5. doi: 10.1111/jgh.12740.
6
Glucagon-like peptide-2 increases dysplasia in rodent models of colon cancer.胰高血糖素样肽-2 增加结直肠癌啮齿动物模型的异型增生。
Am J Physiol Gastrointest Liver Physiol. 2012 Apr 15;302(8):G840-9. doi: 10.1152/ajpgi.00505.2011. Epub 2012 Feb 9.
7
New Peptide Inhibitor of Dipeptidyl Peptidase IV, EMDB-1 Extends the Half-Life of GLP-2 and Attenuates Colitis in Mice after Topical Administration.二肽基肽酶IV的新型肽抑制剂EMDB-1可延长GLP-2的半衰期并减轻小鼠局部给药后的结肠炎。
J Pharmacol Exp Ther. 2017 Oct;363(1):92-103. doi: 10.1124/jpet.117.242586. Epub 2017 Jul 19.
8
Acute effects of the glucagon-like peptide 2 analogue, teduglutide, on intestinal adaptation in short bowel syndrome.胰高血糖素样肽2类似物替度鲁肽对短肠综合征肠道适应性的急性影响。
J Pediatr Gastroenterol Nutr. 2014 Jun;58(6):694-702. doi: 10.1097/MPG.0000000000000295.
9
Berberine ameliorates chronic relapsing dextran sulfate sodium-induced colitis in C57BL/6 mice by suppressing Th17 responses.小檗碱通过抑制 Th17 反应改善 C57BL/6 小鼠慢性复发型葡聚糖硫酸钠诱导的结肠炎。
Pharmacol Res. 2016 Aug;110:227-239. doi: 10.1016/j.phrs.2016.02.010. Epub 2016 Mar 9.
10
Pharmacological Characterization of Apraglutide, a Novel Long-Acting Peptidic Glucagon-Like Peptide-2 Agonist, for the Treatment of Short Bowel Syndrome.阿普列肽,一种新型长效肽类胰高血糖素样肽-2 激动剂,用于治疗短肠综合征的药理学特征。
J Pharmacol Exp Ther. 2020 May;373(2):193-203. doi: 10.1124/jpet.119.262238. Epub 2020 Feb 19.

引用本文的文献

1
Therapeutic peptides: chemical strategies fortify peptides for enhanced disease treatment efficacy.治疗性肽:强化肽以提高疾病治疗效果的化学策略。
Amino Acids. 2025 May 8;57(1):25. doi: 10.1007/s00726-025-03454-5.
2
The Potential of Peptide-Based Inhibitors in Disrupting Protein-Protein Interactions for Targeted Cancer Therapy.基于肽的抑制剂在破坏蛋白质-蛋白质相互作用以进行靶向癌症治疗中的潜力。
Int J Mol Sci. 2025 Mar 28;26(7):3117. doi: 10.3390/ijms26073117.
3
Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines.
基于肽的药物研发进展:递送平台、治疗药物与疫苗
Signal Transduct Target Ther. 2025 Mar 5;10(1):74. doi: 10.1038/s41392-024-02107-5.
4
Direct inhibition of tumor hypoxia response with synthetic transcriptional repressors.用合成转录抑制因子直接抑制肿瘤缺氧反应。
Nat Chem Biol. 2025 Feb;21(2):247-255. doi: 10.1038/s41589-024-01716-z. Epub 2024 Aug 30.
5
Differential Responses of the GLP-1 and GLP-2 Receptors to N-Terminal Modification of a Dual Agonist.双重激动剂 N 端修饰对 GLP-1 和 GLP-2 受体的差异反应。
J Am Chem Soc. 2023 Jun 7;145(22):12105-12114. doi: 10.1021/jacs.3c01628. Epub 2023 May 26.
6
Antidiabetic drugs for IBD: a long but promising road ahead for drug repositioning to target intestinal inflammation.用于炎症性肠病的抗糖尿病药物:药物重新定位以靶向肠道炎症的道路漫长但前景光明。
J Gastroenterol. 2023 Jun;58(6):598-599. doi: 10.1007/s00535-023-01983-y. Epub 2023 Mar 24.
7
Biodegradable Polymeric Nanoparticles Loaded with Flavonoids: A Promising Therapy for Inflammatory Bowel Disease.载有类黄酮的可生物降解聚合物纳米粒子:治疗炎症性肠病的有前途的疗法。
Int J Mol Sci. 2023 Feb 23;24(5):4454. doi: 10.3390/ijms24054454.
8
Strategies to improve the physicochemical properties of peptide-based drugs.提高基于肽的药物理化性质的策略。
Pharm Res. 2023 Mar;40(3):617-632. doi: 10.1007/s11095-023-03486-0. Epub 2023 Mar 3.
9
Targeting MYC with modular synthetic transcriptional repressors derived from bHLH DNA-binding domains.靶向 MYC 的模块化合成转录阻遏物来自 bHLH DNA 结合域。
Nat Biotechnol. 2023 Apr;41(4):541-551. doi: 10.1038/s41587-022-01504-x. Epub 2022 Oct 27.
10
S100 Proteins as Novel Therapeutic Targets in Psoriasis and Other Autoimmune Diseases.S100 蛋白作为银屑病和其他自身免疫性疾病的新型治疗靶点。
Molecules. 2022 Oct 6;27(19):6640. doi: 10.3390/molecules27196640.